| Abstract [eng] |
This prospective longitudinal study investigates the multidimensional impact of facial basal cell carcinoma (BCC) on patient quality of life (QoL), psychological well-being, aesthetic outcomes, and care-seeking behavior before and after surgical intervention. Conducted at Vilnius University Hospital Santaros Klinikos from November 2022 to April 2024, the study enrolled 278 patients with histologically confirmed facial BCC. Patient-reported outcome measures—including the Skin Cancer Index (SCI), Dermatology Life Quality Index, Patient and Observer Scar Assessment Scale (POSAS 2.0), WHO-5 Well-Being Index, and Rosenberg Self-Esteem Scale—were administered preoperatively and at one and six months post-surgery. Statistical analyses (t-tests, ANOVA, regression, and confirmatory factor analysis) demonstrated significant postoperative improvements in QoL (SCI +8.83, p < 0.001), with greater scar dissatisfaction and distress reported among women, younger patients, and those with tumors in visible facial zones. Care-seeking behavior correlated with symptom visibility and pain, whereas subtle symptoms led to delayed consultations and disease progression. The Lithuanian versions of SCI and POSAS 2.0 showed excellent psychometric properties. The study emphasizes the need for a patient-centered, multidisciplinary approach that integrates surgical, psychological, and aesthetic considerations in the treatment of facial BCC. |
